TGFBR1 variants TGFBR1*6A and Int7G24A are not associated with an increased familial colorectal cancer risk

British Journal of Cancer

Volumn 100, Issue 10, 2009, Pages 1674-1679

  Skoglund Lundin, J ^a   Vandrovcova, J ^a   Song, B ^a,b   Zhou, X ^a   Zelada Hedman, M ^a   Werelius, B ^a   Houlston, R S ^c   Lindblom, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Adenoma; Colorectal cancer; Int7G24A; TGFBR1; TGFBR1*6A

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS; YOUNG ADULT;

EID: 67349205051     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605054     Document Type: Article

References (39)

1. Altman DG (1991) Categorising continuous variables. Br J Cancer 64: 975
2. Baxter SW, Choong DY, Eccles DM, Campbell IG (2002) Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 11: 211-214
3. Bian Y, Caldes T, Wijnen J, Franken P, Vasen H, Kaklamani V, Nafa K, Peterlongo P, Ellis N, Baron JA, Burn J, Moeslein G, Morrison PJ, Chen Y, Ahsan H, Watson P, Lynch HT, de la Chapelle A, Fodde R, Pasche B (2005) TGFBR1*6A may contribute to hereditary colorectal cancer. J Clin Oncol 23: 3074-3078
4. Chen T, de Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, Hildesheim A, Reiss M (1999) Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 82: 43-51
5. Chen T, Jackson C, Costello B, Singer N, Colligan B, Douglass L, Pemberton J, Deddens J, Graff JR, Carter JH (2004) An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. Int J Cancer 112:420-425
6. Chen T, Jackson CR, Link A, Markey MP, Colligan BM, Douglass LE, Pemberton JO, Deddens JA, Graff JR, Carter JH (2006) Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer. Clin Cancer Res 12: 392-397
7. Chen T, Triplett J, Dehner B, Hurst B, Colligan B, Pemberton J, Graff JR, Carter JH (2001) Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res 61: 4679-4682
8. Cottet V, Pariente A, Nalet B, Lafon J, Milan C, Olschwang S, Bonaiti-Pellie C, Faivre J, Bonithon-Kopp C (2007) Colonoscopic screening of first- degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 133: 1086-1092
9. Cuzick J (1985) A method for analysing case-control studies with ordinal exposure variables. Biometrics 41: 609-621
10. Daley D, Morgan W, Lewis S, Willis J, Eiston RC, Markowitz SD, Wiesner GL (2007) Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia? Cancer Epidemiol Biomarkers Prev 16: 892-894
11. Derynck R, Akhurst RJ, Balmain A (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129
12. Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R (1993) Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science 260: 1344-1348
13. Houlston RS, Peto J (2003) The future of association studies of common cancers. Hum Genet 112: 434-435
14. Jacobson JS, Neugut AI (1996) Epidemiology of gastrointestinal polyps. Surg Oncol Clin N Am 5: 531-544
15. Kaklamani V, Pasche B (2005) Transforming growth factor beta and breast cancer. Cancer Treat Res 126: 129-156
16. Kemp ZE, Carvajal-Carmona LG, Barclay E, Gorman M, Martin L, Wood W, Rowan A, Donohue C, Spain S, Jaeger E, Evans DG, Mäher ER, Bishop T, Thomas H, Houlston R, Tomlinson I (2006) Evidence of linkage to chromosome 9q22.33 in colorectal cancer kindreds from the United Kingdom. Cancer Res 66: 5003-5006
17. Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, Papadopoulos N, Kinzler KW, Vogelstein B, Peltomaki P, Kolodner RD, Nilbert M, Lindblom A (2007) Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 99: 291-299
18. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78 - 85
19. Liljegren A, Lindblom A, Rotstein S, Nilsson B, Rubio C, Jaramillo E (2003) Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut 52: 1140-1147
20. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775 - 785
21. Lindgren G, Liljegren A, Jaramillo E, Rubio C, Lindblom A (2002) Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 50: 228-234
22. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med MS: 919-932
23. Muller AD, Sonnenberg A (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case - control study of 32 702 veterans. Ann Intern Med 123: 904-910
24. Neugut AI, Jacobson JS, De Vivo I (1993) Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2: 159-176
25. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543
26. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550
27. Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massague J, Offit K (1999) TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 59: 5678-5682
28. Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, Peteriongo P, Ellis N, Offit K, Caldes T, Reiss M, Zheng T (2004) TGFBR1*6A and cancer: a metaanalysis of 12 case-control studies. J Clin Oncol 22: 756-758
29. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S (1997) A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89: 1758-1762
30. Skoglund J, Djureinovic T, Zhou XL, Vandrovcova J, Renkonen E, Iselius L, Bisgaard ML, Peltomaki P, Lindblom A (2006) Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet 43: e7
31. Skoglund J, Song B, Dalen J, Dedorson S, Edler D, Hjern F, Holm J, Lenander C, Lindforss U, Lundqvist N, Olivecrona H, Olsson L, Pahlman L, Rutegard J, Smedh K, Tornqvist A, Houlston RS, Lindblom A (2007) Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Clin Cancer Res 13: 3748-3752
32. Spillman MA, Schildkraut JM, Halabi S, Moorman P, Calingaert B, Bentley RC, Marks JR, Murphy S, Berchuck A (2005) Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk. Gynecol Oncol 97: 543-549
33. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96: 261-268
34. Valle L, Serena-Acedo T, Liyanarachchi S, Hampel H, Comeras I, Li Z, Zeng Q, Zhang HT, Pennison MJ, Sadim M, Pasche B, Tanner SM, de la Chapelle A (2008) Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 321: 1361 - 1365
35. Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34: 424-425
36. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116: 1453-1456
37. Wiesner GL, Daley D, Lewis S, Ticknor C, Platzer P, Lutterbaugh J, MacMillen M, Baliner B, Willis J, Eiston RC, Markowitz SD (2003) A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc Natl Acad Sci USA 100: 12961 - 12965
38. Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, Hall D, Hamlin JA, Schapiro M, O'Brien MJ, Sternberg SS, Gottlieb LS (2000) A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group.N Engl J Med 342: 1766 - 1772
39. Zhang HT, Fei QY, Chen F, Qi QY, Zou W, Wang JC, Zhang RM, Tao SH, Chen XF, Luo ZW (2003) Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer. Lung Cancer 40: 281-287